Biolink.Tech (Biolink Technologies)

The Biolink.Tech company develops the AI tools in medicine.

History

2020

The investment attraction from "The alphabet of taste"

On September 11, 2020 "The alphabet of taste" announced investment into Biolink Tech. Within the transaction of the company through joint efforts will develop in Russia the system of personalisation of a power supply on the basis of blood tests with a possibility of purchase and the product delivery of Otri.

Investment volume of "The alphabet of taste" into Biolink Tech was £337 thousand (about 33.2 million rubles). It is about the first case when the Russian retailer invested in a startup, having become its shareholder, RBC notes.

The startup will direct the involved investments to marketing, development of a product and expansion of a technical command. In future Biolink.Tech is going to start subscription model of sales Otri for corporate clients, the co-founder of Biolink.Tech Evgeny Chereshnev told.

"The alphabet of taste" invested in a technology startup of Biolink Tech which recommends a power supply according to medical analyses

The Otri system allows to order testing of blood with departure on the house, on the basis of analysis results and their comparison to data on physical activity of the person the doctor draws the conclusion and personal recommendations about a power supply and formation of habits. Doctors of Otri are helped by artificial intelligence: the neuronet is trained to distinguish analysis results and to create the recommendations similar to what doctors give on their basis, at the same time the final conclusion confirms and the doctor-biochemist signs.

Retail personalisation — the direction of development, very interesting to us — the vice president of "The alphabet of taste" Georgy Mikhaylov says. — Care of health and a power supply concerns more and more people, and it should become the simplest and technological. We see high potential in partnership with Biolink.Tech, their technologies are checked including long personal experience. Already today thanks to product integration of "The alphabet of taste" and Otri we can offer our clients earlier inaccessible level of knowledge of the choice concerning the diet and food.

According to Mikhaylov, integration with Otri will add "unique selling proposition to the retailer, and in the long term will allow to occupy jointly the new, only appearing in the market niche".^[1]

Development of the platform for weight loss and control of diabetes

For July, 2020 Biolink.Tech is engaged in development of the platform for weight loss and control of diabetes. The company collects unique state-of-health data of health of the user using own sensors and devices of partners and uses the protected personal data on the state of health for integration into program control with AI for the purpose of ensuring loss of weight. The company offers the platform as addition for partners of B2B2C who can add own methodologies, applications and the software to offer a full service package for health and wellbeing to millions of clients.

2017: Basis

The Biolink.Tech company is founded in 2017 by Evgeny Chereshnev - the visionary and the inventor "digital DNA". The company began with the fact that began to help millions of people to get rid of obesity and type 2 diabetes.